Steven M Smith1,2, Tianyao Huo3, Yan Gong1, Eileen Handberg3, Martha Gulati4, C Noel Bairey Merz5, Carl J Pepine3, Rhonda M Cooper-DeHoff1,3. 1. 1 Department of Pharmacotherapy & Translational Research, College of Pharmacy, University of Florida , Gainesville, Florida. 2. 2 Department of Community Health & Family Medicine, College of Medicine, University of Florida , Gainesville, Florida. 3. 3 Division of Cardiology, Department of Medicine, College of Medicine, University of Florida , Gainesville, Florida. 4. 4 Division of Cardiology, University of Arizona College of Medicine-Phoenix , Phoenix, Arizona. 5. 5 Barbara Streisand Women's Heart Center, Cedars-Sinai Heart Institute , Los Angeles, California.
Abstract
BACKGROUND: Women are at greater risk of developing resistant hypertension (RH) than men, yet scarce data exist on RH-associated outcomes in women. We aimed to determine all-cause mortality risk associated with apparent RH (aRH) among women across the spectrum of underlying coronary disease. MATERIALS AND METHODS: We analyzed data from St. James Women Take Heart (WTH; women without coronary disease at baseline), Women's Ischemia Syndrome Evaluation (women with signs/symptoms of ischemia at baseline), and the INternational VErapamil-Trandolapril STudy (INVEST; women with coronary artery disease and hypertension at baseline), totaling 15,108 adult women with no hypertension, non-RH (blood pressure [BP] ≥140/90 mmHg on ≤2 drugs or BP <140/90 mmHg on 1-3 drugs), or aRH (BP ≥140/90 mmHg on ≥3 drugs or anyone on ≥4 drugs) at baseline. The primary outcome was all-cause mortality. RESULTS: Prevalence of aRH ranged from 0.4% (WTH) to 10.6% (INVEST). Women with aRH, compared to those without, were older, more often black, and more likely to be obese or diabetic. Pooling all cohorts, risk for all-cause death was greater in women with aRH than in women with non-RH (adjusted HR 1.40; 95% CI 1.27-1.55) and women without hypertension (adjusted HR 2.34; 95% CI 1.76-3.11) over a median follow-up of 14.3 years. CONCLUSIONS: aRH prevalence in women varies according to underlying coronary disease, and aRH is associated with a substantial, early, and sustained increased risk of all-cause death. Additional research into early recognition and prevention strategies for RH are needed, especially in black and older women, and those with known cardiovascular risk factors.
BACKGROUND:Women are at greater risk of developing resistant hypertension (RH) than men, yet scarce data exist on RH-associated outcomes in women. We aimed to determine all-cause mortality risk associated with apparent RH (aRH) among women across the spectrum of underlying coronary disease. MATERIALS AND METHODS: We analyzed data from St. James Women Take Heart (WTH; women without coronary disease at baseline), Women's Ischemia Syndrome Evaluation (women with signs/symptoms of ischemia at baseline), and the INternational VErapamil-Trandolapril STudy (INVEST; women with coronary artery disease and hypertension at baseline), totaling 15,108 adult women with no hypertension, non-RH (blood pressure [BP] ≥140/90 mmHg on ≤2 drugs or BP <140/90 mmHg on 1-3 drugs), or aRH (BP ≥140/90 mmHg on ≥3 drugs or anyone on ≥4 drugs) at baseline. The primary outcome was all-cause mortality. RESULTS: Prevalence of aRH ranged from 0.4% (WTH) to 10.6% (INVEST). Women with aRH, compared to those without, were older, more often black, and more likely to be obese or diabetic. Pooling all cohorts, risk for all-cause death was greater in women with aRH than in women with non-RH (adjusted HR 1.40; 95% CI 1.27-1.55) and women without hypertension (adjusted HR 2.34; 95% CI 1.76-3.11) over a median follow-up of 14.3 years. CONCLUSIONS: aRH prevalence in women varies according to underlying coronary disease, and aRH is associated with a substantial, early, and sustained increased risk of all-cause death. Additional research into early recognition and prevention strategies for RH are needed, especially in black and older women, and those with known cardiovascular risk factors.
Entities:
Keywords:
INVEST; WISE; hypertension; mortality; resistant hypertension; women
Authors: Marguerite R Irvin; Daichi Shimbo; Devin M Mann; Kristi Reynolds; Marie Krousel-Wood; Nita A Limdi; Daniel T Lackland; David A Calhoun; Suzanne Oparil; Paul Muntner Journal: J Clin Hypertens (Greenwich) Date: 2012-08-03 Impact factor: 3.738
Authors: Stacie L Daugherty; Frederick A Masoudi; Jennifer L Ellis; P Michael Ho; Julie A Schmittdiel; Heather M Tavel; Joe V Selby; Patrick J O'Connor; Karen L Margolis; David J Magid Journal: J Hypertens Date: 2011-05 Impact factor: 4.844
Authors: Sripal Bangalore; Rana Fayyad; Rachel Laskey; David A Demicco; Prakash Deedwania; John B Kostis; Franz H Messerli Journal: Am J Med Date: 2013-11-07 Impact factor: 4.965
Authors: Sreekanth Vemulapalli; Jamy Ard; George L Bakris; Deepak L Bhatt; Alan S Brown; William C Cushman; Keith C Ferdinand; John M Flack; Jerome L Fleg; Barry T Katzen; John B Kostis; Suzanne Oparil; Chet B Patel; Carl J Pepine; Ileana L Piña; Krishna J Rocha-Singh; Raymond R Townsend; Eric D Peterson; Robert M Califf; Manesh R Patel Journal: Am Heart J Date: 2014-02-28 Impact factor: 4.749
Authors: David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey Journal: Hypertension Date: 2008-04-07 Impact factor: 10.190
Authors: Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood Journal: Eur Heart J Date: 2013-06-14 Impact factor: 29.983
Authors: Steven M Smith; Tianyao Huo; B Delia Johnson; Vera Bittner; Sheryl F Kelsey; Diane Vido Thompson; C Noel Bairey Merz; Carl J Pepine; Rhonda M Cooper-Dehoff Journal: J Am Heart Assoc Date: 2014-02-28 Impact factor: 5.501
Authors: John P Konhilas; Jessica N Sanchez; Jessica A Regan; Eleni Constantopoulos; Marissa Lopez-Pier; Danielle K Cannon; Rinku Skaria; Laurel A McKee; Hao Chen; Yulia Lipovka; Dennis Pollow; Heddwen L Brooks Journal: Am J Physiol Heart Circ Physiol Date: 2020-05-08 Impact factor: 4.733
Authors: Jocelyn S Gandelman; Omair A Khan; Megan M Shuey; Jacquelyn E Neal; Elizabeth McNeer; Alyson Dickson; April Barnado; Li Wang; Prathima Anandi; William D Dupont; C Michael Stein; Cecilia P Chung Journal: Arthritis Care Res (Hoboken) Date: 2020-04 Impact factor: 4.794
Authors: Fred Stephen Sarfo; Esther Olasoji; Grant P Banfill; Bruce Ovbiagele; Alexis N Simpkins Journal: Am J Hypertens Date: 2022-08-01 Impact factor: 3.080
Authors: Daniel de Oliveira Beraldo; Cássio J Rodrigues; Beata M R Quinto; Marcelo C Batista Journal: J Clin Hypertens (Greenwich) Date: 2020-11-08 Impact factor: 3.738
Authors: Steven M Smith; Matthew J Gurka; David A Calhoun; Yan Gong; Carl J Pepine; Rhonda M Cooper-DeHoff Journal: Am J Med Date: 2018-08-22 Impact factor: 4.965
Authors: Roberto Manfredini; Nicola Lamberti; Fabio Manfredini; Sofia Straudi; Fabio Fabbian; Maria Aurora Rodriguez Borrego; Nino Basaglia; Juan Manuel Carmona Torres; Pablo Jesus Lopez Soto Journal: J Womens Health (Larchmt) Date: 2018-09-15 Impact factor: 2.681